Dr. Evan Norman Dunn, MD

Dr. Dunn practices at Seashore Retina in Wesley Chapel, Florida.

Dr. Dunn's NPI, 1972879484, was assigned on March 29, 2012. Dr. Dunn graduated from University of Miami, Miller School of Medicine in 2012. Dr. Dunn's Illinois license number on file is 036.140048.

Dr. Dunn's primary practice is Seashore Retina, at 2400 Cypress Glen Dr, Wesley Chapel, FL 33544 in Pasco County. The practice phone is (216) 235-7061.

Dr. Dunn's primary practice is Seashore Retina in Wesley Chapel, Florida. Dmand AI also links Dr. Dunn to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dunn practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Dunn's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Dunn is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Dunn's licenses on file in 3 states: Illinois, Florida and Indiana.

Dmand AI lists age-related macular degeneration, cataract, dry eye, eyelid inflammation, glaucoma, hypertensive retinopathy, inflammation of iris and laser destruction of retinal or choroid lesions among the conditions Dr. Dunn treats.

CMS data shows 293,761 Medicare services from Dr. Dunn across 10 procedure codes in 2024, for 367 Medicare patients. Medicare paid $1,140,581 for them. Every service was in an office.

CMS counts 367 Medicare patients who saw Dr. Dunn in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dunn's median patient age at 69, with 54% women.

In 2024, Dr. Dunn wrote 879 Medicare Part D claims for 313 patients. 64% of them were for generic drugs. CMS names the drug for 820 of them, across 17 drugs with 11 or more claims each, at $438,657 in total drug cost. In 2023, CMS named 876 claims across 13 drugs.

Dr. Dunn accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Dunn in 2019. 2019 was the busiest year, with 2. The most frequent topics are Fluorescein Angiography, Tomography, Optical Coherence and Visual Acuity. Dr. Dunn's most frequent co-authors are Nirali P. Bhatt, MD, Felix Yan-Fay Chau, MD and Raquel Goldhardt, MD.

CMS Open Payments shows 267 general payments to Dr. Dunn from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $6,729.

Dmand AI lists 3 awards for Dr. Dunn.

Dr. Dunn graduated from University of Miami, Miller School of Medicine in 2012.

Dr. Dunn is in network with 18 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.